An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
Clinical trial NCT04434248 · UNKNOWN
Trial details
- NCT number
- NCT04434248
- Sponsor
- Chromis LLC
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-23
- Primary completion
- 2020-07-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.